ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank-check company sponsored by ARYA Sciences Holdings IV, an affiliate of Perceptive Advisors, a life-sciences-focused investment firm. The vehicle completed its initial public offering in 2021, targeting acquisition opportunities across the healthcare and biotechnology sector. As of its 10-Q filing with the SEC dated August 8, 2022, ARYD remained in the search phase, actively evaluating potential merger candidates. ARYD represents the fourth SPAC in Perceptive Advisors' ARYA Sciences series, reflecting the sponsor's sustained institutional focus on life-sciences deal-making. Sign up at SpacDesk for full filing history, timeline data, and analytics on ARYD and the broader SPAC universe.